The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $35.10

Today's change+0.05 +0.14%
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $35.10

Today's change+0.05 +0.14%
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.

Abiomed Inc Hits New 52-week High

Abiomed Inc closed up Friday by (U.S.)$0.05 or 0.14% to (U.S.)$35.10 and setting a new 52-week high. Over the last five days, shares have gained 5.56% and are currently 1.79% off of the 52-week high. Shares have outperformed the S&P 500 by 8.82% during the last year.

Key company metrics

  • Open(U.S.) $35.56
  • Previous close(U.S.) $35.05
  • High(U.S.) $35.74
  • Low(U.S.) $34.70
  • Bid / Ask-- / --
  • YTD % change+31.26%
  • Volume383,410
  • Average volume (10-day)485,473
  • Average volume (1-month)497,085
  • Average volume (3-month)311,632
  • 52-week range(U.S.) $20.29 to (U.S.) $35.74
  • Beta1.79
  • Trailing P/E147.00×
  • P/E 1 year forward214.02×
  • Forward PEG9.95×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.24
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.14%

Based on its net profit margin of 5.14%, Abiomed Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.24%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue52495046
Total other revenue--------
Total revenue52495046
Gross profit42394037
Total cost of revenue1010109
Total operating expense48504742
Selling / general / administrative29322924
Research & development9988
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4-245
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4-145
Income after tax4-244
Income tax, total0000
Net income4-244
Total adjustments to net income--------
Net income before extra. items4-244
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4-244
Inc. avail. to common incl. extra. items4-244
Diluted net income4-244
Dilution adjustment--000
Diluted weighted average shares42404242
Diluted EPS excluding extraordinary itemsvalue per share0.09-0.040.090.11
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.09-0.040.090.11